STJ St. Jude Medical Inc.
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
- 19.27 P/E
- 3.29 P/S
- 4.49 P/B
- 3.46 EPS
- 14.54% Cash ROIC
- 0.54 Cash Ratio
- 1.16 / 1.8% Dividend
- 2.13M Avg. Vol.
- 281.24M Shares
- 18.75B Market Cap.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
Barron's - Mar 19, 2015
St. Jude Medical's "Sell" Rating Reiterated at Canaccord Genuity (STJ) - The Legacy
Minneapolis Star Tribune - Mar 24, 2015
WKRB News - Mar 26, 2015
Forbes - Mar 25, 2015
The Markets Daily - 14 hours ago
This Week's Pre-Market Insights: The First Bancorp, Inc. (FNLC), St. Jude ... - WallStreet Scope
Minneapolis Star Tribune - Mar 12, 2015
Dakota Financial News - Mar 18, 2015
Losing Stocks Analysis Report - California Resources (NYSE:CRC), Micron ... - wsnewspublishers
Wall Street Pulse - Mar 2, 2015
Stocks Highlights:St. Jude Medical (STJ), Wyndham Worldwide (WYN), Pentair ... - Techsonian (press release)
Mideast Time - Mar 26, 2015
Schaeffers Research (blog) - Mar 18, 2015